Skip to main content
Caplight Logo









Soliome

Soliome

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://soliome.com

Last Round

Grant

Aug 15, 2024

Total Funding Raised

$1.27M

Company Overview

Soliome operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Grant round in August 2024.

Soliome is a biotechnology company that develops high-performance, protein-based sun protection solutions designed to be safe for humans and the environment.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Fashion & Beauty

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Soliome Comparables

Compare Soliome with similar companies based on industry and business-model similarity.

Soliome comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Seaspire
86%
Solio Bio
86%
Cambrium
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Soliome Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantAug 15, 2024
GrantSep 15, 2022
GrantSep 15, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Soliome Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 15, 2024

    Secured $1M from the National Science Foundation.

  • Sep 15, 2022

    $256K grant received from the National Science Foundation.

Book a demo to see all signals

For institutional investors. Book with your work email.

Soliome Filings

Explore SEC and related filing metadata, where available.

Soliome filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Soliome's valuation, stock price, and market status.

Is Soliome a public or private company?

Soliome is a private company.

What is the current stock price of Soliome?

Soliome is a private company, so its shares have no public market price. Caplight tracks Soliome's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Soliome worth (valuation)?

Valuation information for Soliome is not publicly available.

Can I buy Soliome stock?

Soliome shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Soliome's last funding round?

Soliome's most recent funding round was Grant on August 15, 2024.

Who are the main investors in Soliome?

Key investors in Soliome include Ray C. Anderson Foundation, The Biomimicry Institute, National Science Foundation.

Will Soliome IPO soon?

No public IPO plans have been announced for Soliome.

How can I track Soliome secondary market activity?

Caplight tracks bids, offers, and trades in Soliome's shares on secondary markets.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range3
Year Founded2021
Last FundingAug 15, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?